We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“I felt that the guidelines represent such an enormous investment by so many experts—the authors, commenters, and reviewers—and we end up publishing them and they come out with a flurry of activity over a short period of time. But then they sort of pass, and maybe there isn't an opportunity to truly reflect on them—their content, the controversies, the issues they raise, the changes.”
“If you are high bleeding risk, the guidelines mention multiple de-escalation strategies, such as de-escalation to P2Y12 monotherapy, or in patients who have an indication for oral anticoagulation, dropping aspirin, for example.”
“My only concern is that I hope that clinicians don't get confused, because at the end of the day, the guidelines are [what] should be guiding clinical practice. Some of these other things are obviously perspectives and they should be taken into account when guidelines are revised, but I hope that people don't come away by thinking that there are some sort of conflicting kinds of recomm[endations].”
No takes yet. Share an insight, caveat, or question.
Kaul et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: